Implant-Associated Infections-Solution

Due to the late onset of symptoms and biofilm resistance to antibiotics, there is currently no satisfactory treatment for patients with P. acnes and S. epidermidis implant-associated infections.

Our prophylactic therapy is designed to specifically target the proteins which facilitate bacterial survival and evasion of host immune response, to prevent implant-associated infections caused by the virulent strains of these two skin-colonizing bacteria.

Our products could be administered to implant recipients several weeks before the scheduled implant surgery in order to establish a sufficient immune response to prevent implant infections by these two bacterial species.

implant associated infections solution - origimm biotechnology, vienna-